Literature DB >> 4075148

Pontine and mesencephalic substrates of self-stimulation.

P P Rompre, E Miliaressis.   

Abstract

Single or twin, moveable monopolar stimulating electrodes were implanted in male adult rats in order to map the medial pons and mesencephalon for self-stimulation behaviour. The electrodes were implanted 6 mm below the surface of the skull and subsequently moved down by steps of 0.13 or 0.16 mm. Each bar press in a Skinner box delivered a train (0.4 s in duration) of cathodal rectangular pulses of fixed intensity (200 microA) and width (0.1 ms). Self-stimulation was recorded from zero to the maximum performance by varying the number of pulses per stimulating train. The rewarding efficacy of the stimulation at each electrode location was inferred from determination of the pulse period corresponding to the threshold and half-maximal performance. Out of 361 mesencephalic and pontine sites sampled, 289 supported self-stimulation. Within the metencephalon, the study revealed a continuous band of positive sites, extending over a dorso-ventral distance of 4 mm, between the floor of the aqueduct and the pontine nuclei. Hence, all electrode locations in the central grey, dorsal raphe and median raphe supported self-stimulation. Within the mesencephalon, the positive band was restricted between the floor of the central grey and the middle part of the interpeduncular nucleus. At the rostral mesencephalon, it shifted laterally towards the substantia nigra. The overlap between the self-stimulation sites and some of the best known ascending and descending pathways is discussed.

Entities:  

Mesh:

Year:  1985        PMID: 4075148     DOI: 10.1016/0006-8993(85)91435-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  24 in total

Review 1.  Self-stimulation: a rewarding decade.

Authors:  C H Bielajew; T Harris
Journal:  J Psychiatry Neurosci       Date:  1991-09       Impact factor: 6.186

2.  Coding of task reward value in the dorsal raphe nucleus.

Authors:  Ethan S Bromberg-Martin; Okihide Hikosaka; Kae Nakamura
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 3.  Drive and Reinforcement Circuitry in the Brain: Origins, Neurotransmitters, and Projection Fields.

Authors:  Roy A Wise; Ross A McDevitt
Journal:  Neuropsychopharmacology       Date:  2017-10-06       Impact factor: 7.853

Review 4.  Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory.

Authors:  Satoshi Ikemoto
Journal:  Neurosci Biobehav Rev       Date:  2010-02-10       Impact factor: 8.989

5.  Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence.

Authors:  M Diana; M Pistis; S Carboni; G L Gessa; Z L Rossetti
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

6.  Mesencephalic substrate of reward: axonal connections.

Authors:  S M Boye; P P Rompré
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

7.  Administration of the GABAA receptor antagonist picrotoxin into rat supramammillary nucleus induces c-Fos in reward-related brain structures. Supramammillary picrotoxin and c-Fos expression.

Authors:  Rick Shin; Satoshi Ikemoto
Journal:  BMC Neurosci       Date:  2010-08-17       Impact factor: 3.288

Review 8.  Dual roles of dopamine in food and drug seeking: the drive-reward paradox.

Authors:  Roy A Wise
Journal:  Biol Psychiatry       Date:  2012-10-05       Impact factor: 13.382

9.  Neuropharmacological evidence for the role of dopamine in ventral pallidum self-stimulation.

Authors:  G Panagis; C Spyraki
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

10.  Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration.

Authors:  Stanley D Glick; Elizabeth M Sell; Isabelle M Maisonneuve
Journal:  Eur J Pharmacol       Date:  2008-10-01       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.